Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US8785450 | AGIOS PHARMS INC | Therapeutic compounds and compositions |
Feb, 2031
(7 years from now) | |
US11254652 | AGIOS PHARMS INC | Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide |
Nov, 2038
(15 years from now) | |
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9682080 | AGIOS PHARMS INC | Pyruvate kinase activators for use in therapy |
May, 2032
(9 years from now) | |
US9980961 | AGIOS PHARMS INC | Pyruvate kinase activators for use in therapy |
May, 2032
(9 years from now) | |
US10632114 | AGIOS PHARMS INC | Pyruvate kinase activators for use in therapy |
May, 2032
(9 years from now) | |
US9193701 | AGIOS PHARMS INC | Pyruvate kinase activators for use in therapy |
Oct, 2032
(9 years from now) | |
US11234976 | AGIOS PHARMS INC | Methods of using pyruvate kinase activators |
Oct, 2038
(15 years from now) |
Exclusivity | Exclusivity Expiration |
---|---|
Orphan Drug Exclusivity (ODE) | Feb 17, 2029 |
New Chemical Entity Exclusivity (NCE) | Feb 17, 2027 |
Drugs and Companies using MITAPIVAT SULFATE ingredient
NCE-1 date: 2026-02-17
Market Authorisation Date: 17 February, 2022
Treatment: Method of using a pyruvate kinase activator for the treatment of hemolytic anemia in adults with pyruvate kinase (pk) deficiency; Method for increasing the lifetime of red blood cells (rbcs) for the t...
Dosage: TABLET;ORAL
29
United States
8
Japan
7
Australia
7
European Union
6
Singapore
6
China
6
Canada
5
Mexico
5
Korea, Republic of
5
Taiwan, Province of China
4
Israel
3
Russia
3
Philippines
3
Brazil
2
South Africa
2
Denmark
2
Slovenia
2
Lithuania
2
Morocco
2
Hungary
2
Costa Rica
2
Argentina
2
Croatia
2
Portugal
2
Cyprus
2
Spain
2
Poland
2
New Zealand
1
Turkey
1
Hong Kong
1
Colombia
1
Malaysia
1
Peru
1
Chile
1
Ecuador
1
RS
1
India
1
Nicaragua
1
Ukraine
1
EA
1
ME
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic